Our rigour, your advantage.
Risk

Concentrated Single-Stock Risk and the Case for Borrowing

For founders, executives, and long-term shareholders, a concentrated position in a single listed company is frequently the dominant feature of their personal balance sheet. The performance of one share price can define decades of wealth creation — or destruction — in a way that no diversified portfolio would permit.

01

Why concentration persists despite the risk

Conventional financial theory recommends diversification as the principal tool for managing equity risk. Yet concentrated single-stock positions are extraordinarily common among high-net-worth individuals and family offices. The reasons are structural: founders typically cannot sell meaningful stakes without triggering regulatory disclosure requirements, damaging market confidence, or breaching lock-up obligations. Executives face similar constraints through insider trading rules and contractual vesting periods. Even investors who are technically free to sell may be deterred by large embedded capital gains taxes that would crystallise on disposal. The result is a cohort of shareholders carrying significant idiosyncratic risk that they recognise but cannot easily reduce by conventional means.

02

The asymmetry of a single-stock position

A concentrated position exposes the shareholder to a form of risk that diversified equity portfolios largely eliminate: company-specific, or idiosyncratic, risk. A single accounting irregularity, a product recall, a regulatory investigation, or an unexpected change in leadership can halve a share price in a matter of days regardless of overall market conditions. The investor who holds ten per cent of their wealth in a company might shrug off such an event. The founder who holds eighty per cent faces a potential catastrophe that affects their lifestyle, their family’s financial security, their philanthropic commitments, and their ability to pursue new ventures. This asymmetry is the central problem concentration creates.

03

How borrowing addresses the concentration problem

Securities-backed borrowing against a concentrated position does not reduce the underlying stock exposure directly — the shares remain held, and their price still determines the value of the position. What borrowing does is unlock the latent capital embedded in those shares without requiring a sale. The proceeds can be deployed into diversified assets, used to fund consumption or investment, or held as a liquidity reserve against future needs. The shareholder retains the economic upside of the shares (including dividends, where applicable) while simultaneously building a separate, diversified financial position. Over time, this approach can meaningfully reduce the proportion of net worth that depends on a single company’s fortunes.

04

Non-recourse structures and downside protection

For shareholders acutely conscious of the tail risk in their concentrated position, a non-recourse term loan offers a meaningful additional benefit. In a non-recourse facility, the lender’s claim on default is limited to the pledged shares. If the company suffers a catastrophic share-price decline — the very risk that most concerns a concentrated holder — the borrower can surrender the shares in satisfaction of the loan without any further personal liability. This effectively creates a floor on the downside: the shareholder captures the loan proceeds regardless of how badly the share price subsequently performs. Structuring the facility with this feature is particularly valuable when the borrower has material concerns about sector-specific or company-specific risks over the loan horizon.

05

Practical considerations for large concentrated positions

Shareholders with concentrated positions large enough to require securities-backed financing typically need a lender with genuine capacity to underwrite in size, a thorough understanding of disclosure and insider-trading obligations, and the discretion to handle sensitive transactions without market disruption. Black Haven Investments acts as principal lender across these transactions, structuring facilities that can accommodate large and complex collateral packages. The team works directly with shareholders and their advisers — legal, tax, and financial — to ensure the structure is coherent with each borrower’s wider situation, including any regulatory constraints on pledging or disclosure requirements in the relevant jurisdiction.

FAQ

Frequently asked.

01Does pledging shares count as a disposal for capital gains tax purposes?
In most jurisdictions, pledging shares as collateral for a loan does not itself constitute a disposal for tax purposes, so no capital gains tax event is typically triggered at that stage. However, tax treatment varies by jurisdiction and individual circumstances, and borrowers should obtain specific advice from their tax advisers before proceeding.
02What happens to dividends on shares pledged as collateral?
This depends on the specific terms of the facility. In many structures, the borrower retains the right to receive dividends on pledged shares during the loan term. At Black Haven, dividend treatment is agreed as part of the facility documentation and can be structured to reflect the borrower’s preferences and the lender’s credit requirements.
03Can borrowing against shares trigger insider-trading or disclosure obligations?
In some jurisdictions, pledging shares held by directors, major shareholders, or other insiders can trigger disclosure requirements. The rules vary significantly by market and regulatory framework. Black Haven works with borrowers and their legal advisers to ensure facilities are structured in compliance with applicable requirements, but specific legal advice is essential before any transaction proceeds.

A position to talk through?

Send a confidential enquiry, and a senior principal will reply within one business day.